1. Zhan, Zhi-Qing, Huang, Ze-Min, Lan, Qi-Wen, Sun, Baoqing, Cheng, Zhangkai J. 2024. Integrated multi-omics analyses revealed the association between rheumatoid arthritis and colorectal cancer: MYO9A as a shared gene signature and an immune-related therapeutic target. In BMC cancer, 24, 714. doi:10.1186/s12885-024-12466-5. https://pubmed.ncbi.nlm.nih.gov/38858644/
2. Li, Qi, Gulati, Ashima, Lemaire, Mathieu, Bale, Allen, Tufro, Alda. 2021. Rho-GTPase Activating Protein myosin MYO9A identified as a novel candidate gene for monogenic focal segmental glomerulosclerosis. In Kidney international, 99, 1102-1117. doi:10.1016/j.kint.2020.12.022. https://pubmed.ncbi.nlm.nih.gov/33412162/
3. O'Connor, Emily, Töpf, Ana, Müller, Juliane S, Laval, Steven H, Lochmüller, Hanns. 2016. Identification of mutations in the MYO9A gene in patients with congenital myasthenic syndrome. In Brain : a journal of neurology, 139, 2143-53. doi:10.1093/brain/aww130. https://pubmed.ncbi.nlm.nih.gov/27259756/
4. Li, Qi, Veron, Delma, Tufro, Alda. 2021. S-Nitrosylation of RhoGAP Myosin9A Is Altered in Advanced Diabetic Kidney Disease. In Frontiers in medicine, 8, 679518. doi:10.3389/fmed.2021.679518. https://pubmed.ncbi.nlm.nih.gov/34336885/
5. Guo, Jing, Chen, Li-Wen, Huang, Zhi-Qi, Fang, Xian-Hong, Shan, Zhi-Xin. 2022. Suppression of the Inhibitory Effect of circ_0036176-Translated Myo9a-208 on Cardiac Fibroblast Proliferation by miR-218-5p. In Journal of cardiovascular translational research, 15, 548-559. doi:10.1007/s12265-022-10228-x. https://pubmed.ncbi.nlm.nih.gov/35288823/